Tenaya Therapeutics Cash Flow Statement (2020-2026) | TNYA

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-15.21M-18.26M-26.15M-31.06M-28.40M-30.70M-33.52M-31.74M-33.27M-29.14M-29.93M-32.23M-29.43M-25.63M-23.84M-26.86M-23.28M-20.27M-20.18M-19.27M
Share-based Compensation (Quarter)
0.50M0.97M1.05M2.09M3.01M3.17M3.19M3.51M3.83M4.01M3.95M4.22M4.61M3.91M3.76M3.73M3.63M2.93M-9.20M2.20M
Cash from Operations (Quarter)
-12.02M-16.66M-16.35M-28.76M-25.43M-27.56M-22.68M-30.29M-26.22M-23.64M-21.92M-28.66M-23.62M-19.84M-18.39M-23.11M-15.61M-15.60M-13.94M-19.23M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
0.26M0.31M0.32M0.33M0.46M0.71M0.74M0.75M0.78M0.80M0.81M0.80M0.82M1.03M0.74M0.60M0.61M0.62M0.64M0.65M
Depreciation & Amortization (CF) (Quarter)
0.73M0.75M0.79M0.97M1.30M2.09M2.12M2.13M2.19M2.18M2.18M2.15M2.12M2.10M2.09M2.66M2.08M1.86M1.83M1.76M
Change in Working Capital
Change in Receivables (Quarter)
10.63M
Change in Account Payables (Quarter)
0.74M1.16M6.08M-1.78M-0.34M0.32M3.46M-1.32M1.10M-2.75M-0.30M1.27M-2.43M1.28M-0.70M-0.38M-1.14M-0.45M0.53M-1.46M
Change in Accured Expenses (Quarter)
0.99M1.76M1.57M0.32M0.39M1.34M2.30M-2.66M1.12M1.24M2.56M-4.35M0.60M-1.70M0.71M-1.90M0.39M0.92M1.13M-2.64M
Other Working Capital Changes (Quarter)
0.37M-0.94M1.11M-0.53M-0.67M1.22M-3.12M-0.98M-1.02M-1.06M3.06M-1.06M-1.09M-1.03M3.19M-0.70M-0.70M-0.68M-0.70M10.40M
Investing Activities
Capital Expenditures (Quarter)
-2.37M1.72M0.42M-0.03M0.16M19.70M-19.02M0.63M0.10M0.12M-0.24M0.01M0.63M0.18M-1.48M-0.00M0.53M-1.10M0.00M-0.46M
Change in Acquisitions & Divestments (Quarter)
68.20M59.35M78.70M38.50M34.50M40.48M30.50M1.14M19.72M32.49M20.68M8.32M11.73M-0.77M34.78M
Cash from Investing Activities (Quarter)
-3.24M-168.43M-62.58M16.43M30.21M31.03M5.97M8.06M25.09M30.49M-14.92M-4.49M21.61M-30.10M14.10M22.30M24.99M8.86M-0.07M-0.01M
Financing Activities
Other financing activities (Quarter)
0.03M188.54M-0.06M0.01M1.93M
Change in Capital Stock
Shares Issued (Quarter)
2.10M3.85M2.77M3.15M2.76M5.20M5.21M1.52M8.13M8.22M8.34M0.36M0.78M1.36M9.25M1.19M1.58M12.25M12.05M2.69M
Net Equity Issued and Repurchased (Quarter)
-0.01M46.76M-46.76M46.76M0.91M47.89M-47.89M104.15M
Misc.
Cash from Financing Activities (Quarter)
-1.30M190.27M-0.02M0.01M0.26M0.01M77.49M-0.50M4.18M0.37M46.77M0.57M0.03M0.38M50.26M-0.48M0.38M58.24M-0.41M
Change in Cash (Quarter)
-16.55M5.19M-78.95M-12.31M5.04M3.48M60.78M-22.73M3.04M6.85M-36.47M13.62M-1.43M-49.90M-3.91M49.45M8.90M-6.36M44.23M-19.66M
Free Cash Flow (Quarter)
-9.65M-18.38M-16.77M-28.73M-25.59M-47.26M-3.66M-30.92M-26.32M-23.76M-21.68M-28.67M-24.25M-20.02M-16.91M-23.11M-16.14M-14.50M-13.94M-18.77M
Net Cash Flow (Quarter)
-16.55M5.19M-78.95M-12.31M5.04M3.48M60.78M-22.73M3.04M6.85M-36.47M13.62M-1.43M-49.90M-3.91M49.45M8.90M-6.36M44.23M-19.66M